Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Price Performance

NYSE RVP opened at $1.15 on Thursday. The stock’s 50-day moving average price is $1.06 and its two-hundred day moving average price is $1.14. The company has a current ratio of 11.02, a quick ratio of 8.18 and a debt-to-equity ratio of 0.01. The company has a market cap of $34.43 million, a PE ratio of -4.42 and a beta of 2.07. Retractable Technologies has a 1 year low of $0.87 and a 1 year high of $1.34.

Retractable Technologies (NYSE:RVPGet Free Report) last posted its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $7.60 million during the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%.

Insider Buying and Selling

In other news, CEO Thomas J. Shaw acquired 48,635 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The shares were purchased at an average price of $1.03 per share, for a total transaction of $50,094.05. Following the completion of the acquisition, the chief executive officer now owns 14,417,148 shares of the company’s stock, valued at approximately $14,849,662.44. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last quarter, insiders have bought 138,978 shares of company stock worth $142,065. Insiders own 54.60% of the company’s stock.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

See Also

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.